# Diatrizoate Meglumine and Diatrizoate Sodium

NDC: 53041-690
Generic name: Diatrizoate Meglumine and Diatrizoate Sodium
Labeler / Manufacturer: Guardian Drug Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL, RECTAL
Marketing started: 20191218

FDA application: ANDA214201

## Active ingredients

- DIATRIZOATE MEGLUMINE: 660 mg/mL
- DIATRIZOATE SODIUM: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"53041-690"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=53041-690
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9da4d3d-d0ca-44f7-aaeb-ae49c3839775